Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

The first successes of the immuno-metabolic track in precision psychiatry

Med Sci (Paris). 2025 May;41(5):490-499. doi: 10.1051/medsci/2025063. Epub 2025 May 26.

ABSTRACT

Psychiatric disorders are associated with a high prevalence of cardiovascular and metabolic risk factors such as diabetes, obesity, and metabolic syndrome, as well as specific symptoms: hyperphagia, weight gain, hypersomnia, fatigue, and anhedonia. Non-pharmacological therapeutic strategies (exercise, Mediterranean or ketogenic diets) as well as pharmacological approaches, such as repositioning molecules (metformin or GLP1 receptor agonists), are available and could be proposed to these patients. In addition, targeting immuno-inflammatory pathways may be beneficial for these individuals.

PMID:40418011 | DOI:10.1051/medsci/2025063

Document this CPD

AI-Assisted Evidence Search

Share Evidence Blueprint

QR Code

Search Google Scholar

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review (RAISR4D)